| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |